Literature DB >> 22274542

Role of medical therapy in the management of nasal polyps.

Isam Alobid1, Joaquim Mullol.   

Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory disease of the nasal and paranasal sinus mucosa that, despite differing hypotheses regarding its cause, remains poorly understood. Major symptoms are nasal congestion or blockage, loss of smell, rhinorrhea, postnasal drip, and facial pain or pressure. Among the objectives of CRSwNP management are to eradicate nasal polyps from nasal and sinusal cavities, eliminate symptoms, and prevent recurrences. Corticosteroids are the mainstay of treatment and are the most effective drugs for treating CRSwNP. Other potential treatments are nasal saline irrigation and antihistamines (in allergic conditions). Endoscopic sinus surgery is recommended when medical treatment fails. After surgery, medical treatment, including nasal and oral corticosteroids, is recommended.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274542     DOI: 10.1007/s11882-012-0247-6

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  87 in total

1.  Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol.

Authors:  N Mygind; C B Pedersen; S Prytz; H Sørensen
Journal:  Clin Allergy       Date:  1975-06

2.  The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study.

Authors:  Fenna A Ebbens; Christos Georgalas; Silvia Luiten; Cornelis M van Drunen; Lydia Badia; Glenis K Scadding; Peter W Hellings; Mark Jorissen; Joaquim Mullol; Alda Cardesin; Claus Bachert; Thibaut P J van Zele; Valerie J Lund; W J Fokkens
Journal:  Laryngoscope       Date:  2009-02       Impact factor: 3.325

3.  [Does the use of nasal vasoconstrictor agents change tomodensitometric images of nasosinusal polyposis?].

Authors:  M Elbez; M De Pressigny; P Halimi; D Aidan; P Bonfils; J Trotoux
Journal:  Ann Otolaryngol Chir Cervicofac       Date:  1993

Review 4.  Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis.

Authors:  Helen Beer; Kevin W Southern; Andrew C Swift
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

5.  Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium.

Authors:  J Mullol; E López; J Roca-Ferrer; A Xaubet; L Pujols; J C Fernàndez-Morata; J M Fabra; C Picado
Journal:  Clin Exp Allergy       Date:  1997-12       Impact factor: 5.018

6.  Lower sensitivity of nasal polyp fibroblasts to glucocorticoid anti-proliferative effects.

Authors:  Laura Pujols; Mireya Fuentes-Prado; Laura Fernández-Bertolín; Isam Alobid; Jordi Roca-Ferrer; Joaquim Mullol; César Picado
Journal:  Respir Med       Date:  2010-09-09       Impact factor: 3.415

7.  Budesonide in the treatment of nasal polyposis.

Authors:  E Holopainen; B Grahne; H Malmberg; J Mäkinien; N Lindqvist
Journal:  Eur J Respir Dis Suppl       Date:  1982

8.  A preliminary randomised controlled trial evaluating the efficacy of saline douching following endoscopic sinus surgery.

Authors:  S R M Freeman; E S G Sivayoham; K Jepson; J de Carpentier
Journal:  Clin Otolaryngol       Date:  2008-10       Impact factor: 2.597

9.  Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps.

Authors:  M Tos; F Svendstrup; H Arndal; S Orntoft; J Jakobsen; P Borum; C Schrewelius; P L Larsen; F Clement; C Barfoed; F Rømeling; T Tvermosegaard
Journal:  Am J Rhinol       Date:  1998 May-Jun

10.  Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma.

Authors:  N Ogata; Y Darby; G Scadding
Journal:  J Laryngol Otol       Date:  2007-08-15       Impact factor: 1.469

View more
  9 in total

1.  Long-Term Therapy with Corticosteroids in Nasal Polyposis: A Bone Metabolism Assessment.

Authors:  M Gelardi; F Barbara; I Covelli; M A Damiani; F Plantone; A Notarnicola; B Moretti; N Quaranta; G Ciprandi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-08-01

Review 2.  Clinical and biological markers of difficult-to-treat severe chronic rhinosinusitis.

Authors:  Mauricio López-Chacón; Joaquim Mullol; Laura Pujols
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

3.  Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: an explant model study.

Authors:  Ming Zeng; Zhi-Yong Li; Jin Ma; Ping-Ping Cao; Heng Wang; Yong-Hua Cui; Zheng Liu
Journal:  BMC Immunol       Date:  2015-06-06       Impact factor: 3.615

Review 4.  Pathogenesis of eosinophilic chronic rhinosinusitis.

Authors:  Said Ahmad Shah; Hajime Ishinaga; Kazuhiko Takeuchi
Journal:  J Inflamm (Lond)       Date:  2016-04-06       Impact factor: 4.981

5.  A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps.

Authors:  Robert C Kern; J Pablo Stolovitzky; Stacey L Silvers; Ameet Singh; Jivianne T Lee; David M Yen; Alfred M C Iloreta; Francis P J Langford; Boris Karanfilov; Keith E Matheny; James W Stambaugh; Anna K Gawlicka
Journal:  Int Forum Allergy Rhinol       Date:  2018-01-19       Impact factor: 3.858

6.  Decreased expression of type I (IFN-β) and type III (IFN-λ) interferons and interferon-stimulated genes in patients with chronic rhinosinusitis with and without nasal polyps.

Authors:  Jae Woong Hwang; Ki Jeong Lee; In Hak Choi; Hye Min Han; Tae Hoon Kim; Sang Hag Lee
Journal:  J Allergy Clin Immunol       Date:  2019-08-23       Impact factor: 10.793

7.  Aspirin sensitivity and chronic rhinosinusitis with polyps: a fatal combination.

Authors:  Hendrik Graefe; Christina Roebke; Dirk Schäfer; Jens Eduard Meyer
Journal:  J Allergy (Cairo)       Date:  2012-08-14

8.  In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled Analysis.

Authors:  J Pablo Stolovitzky; Robert C Kern; Joseph K Han; Keith D Forwith; Randall A Ow; Simon K Wright; Andrew Gould; Keith E Matheny; Boris Karanfilov; Saling Huang; James W Stambaugh; Anna K Gawlicka
Journal:  Am J Rhinol Allergy       Date:  2019-05-23       Impact factor: 2.467

Review 9.  Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases.

Authors:  Olavo de Godoy Mion; João Ferreira de Mello; Daniel Lorena Dutra; Nilvano Alves de Andrade; Washington Luiz de Cerqueira Almeida; Wilma Teresinha Anselmo-Lima; Leonardo Lopes Balsalobre Filho; Jair de Carvalho E Castro; Roberto Eustáquio Dos Santos Guimarães; Marcus Miranda Lessa; Sérgio Fabrício Maniglia; Roberto Campos Meireles; Márcio Nakanishi; Shirley Shizue Nagata Pignatari; Renato Roithmann; Fabrizio Ricci Romano; Rodrigo de Paula Santos; Marco César Jorge Dos Santos; Edwin Tamashiro
Journal:  Braz J Otorhinolaryngol       Date:  2017-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.